drugset
drugset / Trial / NCT02249884

Dose-Response Curve: Interventions to Prevent and Treat Radiodermatitis

NCT02249884 ↗

Phase 2 Completed 30 enrolled University of Brasilia University of Washington · collab
RandomizedParallel-groupDouble-blind

Summary

Dose response curve to define the security and tolerable dose to be used for prevention and treatment of radiodermatitis in patients with breast or head and neck cancer.

Timeline

Start
2014-02
Primary completion
2015-03
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Chamomile Traditional medicine (herbal / TCM) — Topical
Subject urea Unknown — Topical

Indications

radiodermatitis